Showing results (421-430 of 442) with videos related to
Sort By:
Pageof 45
Molecular Ecology|November 22, 2024
Population Genetics and Invasion History of the European Starling Across Aotearoa New ZealandBryan Thompson, Kamolphat Atsawawaranunt, Melissa C Nehmens, et al.European Journal of Cancer (Oxford, England : 1990)|September 24, 1999
A pilot study of the safety and effects of the matrix metalloproteinase inhibitor marimastat in gastric cancerG M Tierney, N R Griffin, R C Stuart, et al.The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 4, 2011
Cost of care for colorectal cancer in Ireland: a health care payer perspectiveL Tilson, L Sharp, C Usher, et al.Cancer Research Communications|April 10, 2023
Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal CancerJasleen K Badesha, Marilyn Zhou, Arif A Arif, et al.Therapeutic Advances in Medical Oncology|June 13, 2022
Characterizing the KRAS G12C mutation in metastatic colorectal cancer: a population-based cohort and assessment of expression differences in The Cancer Genome AtlasMeredith Li, Faeze Keshavarz-Rahaghi, Gale Ladua, et al.Seminars in Oncology|September 1, 1984
Mitoxantrone as first-line chemotherapy for advanced breast cancer: results of a European collaborative studyJ F Smyth, M A Cornbleet, R C Stuart-Harris, et al.European Journal of Cancer & Clinical Oncology|September 1, 1984
Mitoxantrone for the treatment of advanced breast cancer: single-agent therapy in previously untreated patientsM A Cornbleet, R C Stuart-Harris, I E Smith, et al.Stroke and Vascular Neurology|September 30, 2017
Taking care of volunteers in a stroke trial: a new assisted-management strategyAmber C Stuart, Jason J Sico, Catherine M Viscoli, et al.British Journal of Cancer|June 27, 2002
Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trialS R Bramhall, M T Hallissey, J Whiting, et al.Pageof 45